Influenza is a contagious respiratory illness that the influenza virus causes leading to the infection of nose, throat, and sometimes the lungs. It can result into mild to severe illness and sometimes can lead to death. Three types of influenza virus affect people that includes: type A, type B, and type C. Influenza is spread via infectious respiratory secretions that is caused by the formation of aerosol due to direct contact with an infected person. The influenza can cause seasonal epidemics along with high levels of mortality and morbidity. A number of factors are responsible for the overall growth of the global influenza diagnostics market. Increasing prevalence of influenza and related chronic disease along with the rising geriatric population base is one of the major factors for the growth of the market. However, increasing price of diagnostic kits and reagents hinder the growth of the market. Moreover, there is a huge opportunity of the global influenza diagnostic market in the near future due to enormous funding and investment, and support provided by the government for influenza diagnostics. For an instance, San Diego-based Cue Health was awarded up to $30 million by the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority. The funding was provided for enhancing the development and regulatory validation of over-the-counter and professional-use influenza and multiplex respiratory pathogen diagnostic cartridges for health monitoring system of the company.

A full report description of Influenza Diagnostics Market at https://www.omrglobal.com/industry-reports/influenza-diagnostics-market

The influenza diagnostics market can be segmented on the basis of, type, test type and end users. Based on the type, the influenza diagnostics market is bifurcated as type A flu, type B flu and type C flu. On the basis of test type, the market is diversified as rapid influenza diagnostic test, serological assay, nucleic acid sequence-based amplification test, loop-mediated isothermal amplification-based assay, simple amplification-based assay and other tests. Based on the end users, the influenza diagnostics market is sub-divided as hospitals, and research labs.

Request a Free Report on Sample of Influenza Diagnostics Market @ https://www.omrglobal.com/request-sample/influenza-diagnostics-market

Market Segmentation

By Type of Flu

• Type A Flu
• Type B Flu
• Type C Flu

By Test Type

• Rapid Influenza Diagnostic Tests (Ridt)
• Serological Assay
• Nucleic Acid Sequence-Based Amplification (Nasba) Tests
• Loop-Mediated Isothermal Amplification-Based Assays (Lamp)
• Simple Amplification-Based Assays (Samba)
• Others

By End Users

• Hospitals & Diagnostic Centers
• Research Labs

Regional Analysis

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

Company Profiles

• ABB Group
• ABS Group (Genesis Technology Solutions, Inc.)
• AssetWorks, LLC
• Carl International SA
• CGI Inc.
• Fujitsu Ltd.
• IBM Corp.
• IFS AB
• Infor
• Mainsaver, Inc.
• MEX
• Microsoft Corp.
• Midmark Corp.
• Oracle Corp.
• Real Asset Management
• SAP SE
• Schneider Electric SE
• Sunflower Systems
• TAZA Corp.
• Ultimo Software Solutions Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/influenza-diagnostics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404